Clinical impact of ABCC1 and ABCC2 genotypes and haplotypes in mediating imatinib resistance among chronic myeloid leukaemia patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical impact of ABCC1 and ABCC2 genotypes and haplotypes in mediating imatinib resistance among chronic myeloid leukaemia patients

Published:2014-07-24 Issue:6 Volume:39 Page:685-690
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Au A.¹,Baba A. A.²³,Azlan H.²,Norsa'adah B.⁴,Ankathil R.¹

Affiliation:

1. Human Genome Centre; School of Medical Sciences; Universiti Sains Malaysia; Kubang Kerian Kelantan Malaysia

2. Department of Internal Medicine and Clinical Hematology; School of Medical Sciences; Universiti Sains Malaysia; Kubang Kerian Kelantan Malaysia

3. School of Medicine; International Medical University; Bukit Jalil Kuala Lumpur Malaysia

4. Unit of Biostatistics and Research Methodology; School of Medical Sciences; Universiti Sains Malaysia; Kubang Kerian Kelantan Malaysia

Funder

APEX Grant

Universiti Sains Malaysia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpt.12197/fullpdf

Reference31 articles.

1. Mechanisms of resistance to imatinib and second-generation tyrosine inhibitors in chronic myeloid leukemia;Milojkovic;Clin Cancer Res,2009

2. BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-frequency and clinical outcome;Elias;Leuk Res,2014

3. Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study;Larson;Blood,2008

4. Emerging new paradigms for ABCG transporters;Tarr;Biochim Biophys Acta,2009

5. Imatinib is a substrate for various multidrug resistance proteins;Czyzewski;Neoplasma,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of MDR-1 Gene Polymorphism (rs1128503) on Response to Imatinib or Nilotinib in Iraqi Patients with Chronic Myeloid Leukemia: An Observational Study;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-03-14

2. Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia;Pharmaceutics;2023-10-26

3. Detachment of Hexokinase II From Mitochondria Promotes Collateral Sensitivity in Multidrug Resistant Chronic Myeloid Leukemia Cells;Frontiers in Oncology;2022-05-26

4. Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib;Frontiers in Oncology;2021-05-13

5. TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562/G01 cells by neutralizing the Wnt/β‑catenin/TCF7/ABC transporter signaling axis;Oncology Reports;2020-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3